Clinical trial related with transplantation therapy with human autologous cell mixed sheets for refractory cutaneous ulcer - Autologous cell mixed sheets transplantation for refractory cutaneous ulcer

Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine0 sites6 target enrollmentMarch 9, 2018

Overview

Phase: 未知
Intervention: Not specified
Conditions: refractory cutaneous ulcer
Sponsor: Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine
Enrollment: 6
Status: Completed
Last Updated: 2 years ago

No summary available.

Registry

who.int

Start Date

March 9, 2018

End Date

March 4, 2021

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine

•1\. Patients suffering from critical limb ischemia. 2\. Patients suffering from malignant neoplasm. 3\. Patients suffering from bacterial infections such as treponema palladium, chlamydia, gonorrhea and tuberculosis. 4\. Patients suffering from infections such as hepatitis B and C viruses, human immunodeficiency virus, human T lymphotropic virus type 1 and parvovirus B19\. 5\. Patients with allergy of local anesthesia. 6\. Hemoglobin: \< 8\.0 g/dL, Plt: \< 50,000 /uL, Prothrombin time: \< 40% 7\. Patients with sepsis or suspected with. 8\. Patients with congenital coagulopathy, antiplatelet drug use, or anticoagulant use. 9\. Patients who have experienced other cell or gene therapy 10\. Patients who join other clinical trials or joined them within 6 months. 11\. Patients with hemodialysis. 12\. Patients who developed unstable angina, myocardial ischemia, or cerebral infarction within 3 months 13\. Pregnant woman and women who may possibly be pregnant, women in nursing 14\. Patients with allergy of aminoglycoside antibiotics. 15\. Patient determined to be ineligible for this clinical study by research attending physician.